Cargando…

Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe

PURPOSE: Advanced non-small-cell lung cancer (aNSCLC; stage IIIB/IV) presents a substantial clinical burden to society; reliable estimates of its economic burden are lacking. Therefore, this study aimed to quantify real-world health care resource utilization (HCRU) and costs of patients with squamou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verleger, Katharina, Penrod, John R, Manley Daumont, Melinda, Solem, Caitlyn, Luo, Linlin, Macahilig, Cynthia, Hertel, Nadine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970261/ https://www.ncbi.nlm.nih.gov/pubmed/32021337 http://dx.doi.org/10.2147/CEOR.S223760

Ejemplares similares

The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions
por: Campbell, David, et al.
Publicado: (2018)

Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease
por: Solem, Caitlyn T, et al.
Publicado: (2013)

Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe
por: Nathwani, Dilip, et al.
Publicado: (2014)

Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey
por: Solem, Caitlyn T, et al.
Publicado: (2014)

Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results‐Medicare data
por: Danese, Mark D., et al.
Publicado: (2021)

Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates
por: El Houfi, Ashraf, et al.
Publicado: (2015)

Cost Containment in Europe
por: Culyer, A. J.
Publicado: (1989)

Malignant pleural mesothelioma: treatment patterns and humanistic burden of disease in Europe
por: Moore, Adam, et al.
Publicado: (2022)

Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014)

Is quality costly? Patient and hospital cost drivers in vascular surgery
por: Kruse, Marie, et al.
Publicado: (2013)

Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis
por: Etemad, Lida R., et al.
Publicado: (2005)

Caregivers of patients with malignant pleural mesothelioma: who provides care, what care do they provide and what burden do they experience?
por: Moore, Adam, et al.
Publicado: (2023)

Households experiencing catastrophic costs due to tuberculosis in Uganda: magnitude and cost drivers
por: Muttamba, Winters, et al.
Publicado: (2020)

Early switch/early discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Brazil
por: Furtado, Guilherme H., et al.
Publicado: (2019)

Depression in Central and Eastern Europe: How Much It Costs? Cost of Depression in Romania
por: Iordache, Miorita Melina, et al.
Publicado: (2023)

Low-Cost Servomotor Driver for PFM Control
por: Aragon-Jurado, David, et al.
Publicado: (2017)

Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative
por: Snee, Michael, et al.
Publicado: (2021)

Major drivers of healthcare system costs and cost variability for routine atrial fibrillation ablation
por: Zenger, Brian, et al.
Publicado: (2022)

Modeling the costs of case management in long-term care
por: Davidson, Gestur B., et al.
Publicado: (1991)

Treatment cost of narcolepsy with cataplexy in Central Europe
por: Maresova, Petra, et al.
Publicado: (2016)

The cost of severe haemophilia in Europe: the CHESS study
por: O’Hara, Jamie, et al.
Publicado: (2017)

The cost of aging: Economic growth perspectives for Europe
por: Jayawardhana, Thaveesha, et al.
Publicado: (2023)

Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia
por: Althaqafi, Abdulhakeem O, et al.
Publicado: (2017)

Catastrophic Costs among Tuberculosis-Affected Households in Egypt: Magnitude, Cost Drivers, and Coping Strategies
por: Ghazy, Ramy Mohamed, et al.
Publicado: (2023)

Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon
por: Alothman, Adel F, et al.
Publicado: (2017)

Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia
por: Matar, Madonna J, et al.
Publicado: (2017)

Cost optimization of induction linac drivers for linear colliders
por: Barletta, W A
Publicado: (1987)

Cost Drivers Associated With Anterior Shoulder Stabilization Surgery
por: Li, Lambert T., et al.
Publicado: (2020)

Perceived human and material costs of disasters as drivers of donations
por: Zagefka, Hanna
Publicado: (2021)

Cost drivers in the pharmacological treatment of interstitial lung disease
por: Maqhuzu, Phillen Nozibuyiso, et al.
Publicado: (2021)

Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysis
por: Carroll, Robert, et al.
Publicado: (2022)

Costs of the COVID‐19 pandemic associated with obesity in Europe: A health‐care cost model
por: Czernichow, Sebastien, et al.
Publicado: (2021)

A systematic review of the indirect costs of schizophrenia in Europe
por: Fasseeh, A, et al.
Publicado: (2018)

New insights into the burden and costs of multiple sclerosis in Europe
por: Kobelt, Gisela, et al.
Publicado: (2017)

The Cost of Von Willebrand Disease in Europe: The CVESS Study
por: Morgan, George, et al.
Publicado: (2022)

The Costs of Dementia in Europe: An Updated Review and Meta-analysis
por: Jönsson, Linus, et al.
Publicado: (2022)

Proton Drivers: prospects in Europe
por: Garoby, R, et al.
Publicado: (2006)

Treatment costs and cost drivers among osteoporotic fracture patients in Japan: a retrospective database analysis
por: Taguchi, Yurie, et al.
Publicado: (2018)

Economic burden of Cardiac Arrest in Spain: analyzing healthcare costs drivers and treatment strategies cost-effectiveness
por: Matilla-García, Mariano, et al.
Publicado: (2023)

Who bears the cost of forest conservation?
por: Poudyal, Mahesh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r12ob2r18gfdnlcd0hojqcm143